LD Micro Main Event Archives - Page 46 of 88

ThursdayDec 07, 2017 1:30 pm

Biomerica, Inc. (NASDAQ: BMRA) Starts Presentation at LD Micro Main Event

Biomerica (NASDAQ: BMRA) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care and in hospital/clinical laboratories for the early detection of medical conditions and diseases. Biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. The Biomerica InFoods IBS product identifies patient specific foods that when removed may alleviate an individual's IBS symptoms. This patent-pending, diagnostic-guided therapy is designed to allow for a patient-specific, guided dietary regimen to improve Irritable Bowel Syndrome (IBS) outcomes. For more information, visit the company’s website at www.biomerica.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

ThursdayDec 07, 2017 1:30 pm

Caladrius Biosciences, Inc. (NASDAQ: CLBS) Starts Presentation at LD Micro Main Event

Caladrius Biosciences (NASDAQ: CLBS) is a clinical stage development company with cell therapy products in development based on multiple technology platforms and targeting autoimmune and select cardiovascular indications. The company is investigating its lead product candidate, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes, in a currently enrolling Phase 2 trial. For more information, visit the company’s website at www.caladrius.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release…

ThursdayDec 07, 2017 1:30 pm

US Nuclear Corp. (UCLE) Starts Presentation at LD Micro Main Event

US Nuclear (OTC: UCLE) is principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others. For more information, visit…

ThursdayDec 07, 2017 1:00 pm

Ampio Pharmaceuticals, Inc. (NYSE: AMPE) Starts Presentation at LD Micro Main Event

Ampio Pharmaceuticals (NYSE MKT: AMPE) is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The company is developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability. For more information, visit the company’s website at http://ampiopharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news…

ThursdayDec 07, 2017 1:00 pm

Digital Ally, Inc. (NASDAQ: DGLY) Starts Presentation at LD Micro Main Event

Digital Ally (NASDAQ: DGLY) specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide. For more information, visit the company’s website at www.digitalallyinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

ThursdayDec 07, 2017 1:00 pm

RadNet, Inc. (NASDAQ: RDNT) Starts Presentation at LD Micro Main Event

RadNet (NASDAQ: RDNT) is a national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 298 owned and/or operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware, New Jersey and New York. In addition, RadNet provides radiology information technology solutions, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. For more information, visit the company’s website at http://www.radnet.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation…

ThursdayDec 07, 2017 12:30 pm

Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) Starts Presentation at LD Micro Main Event

Navidea Biopharmaceuticals (NYSE: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Navidea is developing multiple precision-targeted products based on its ManoceptTM platform to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Navidea’s Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Tc 99m tilmanocept, the first product developed and commercialized by Navidea based on the platform. For more information, visit…

ThursdayDec 07, 2017 12:30 pm

ImmunoCellular Therapeutics Ltd. (NYSE: IMUC) Starts Presentation at LD Micro Main Event

ImmunoCellular Therapeutics (NYSE: IMUC) is a clinical-stage company developing immune-based therapies for the treatment of brain and other cancers. The company’s lead product candidate, ICT-107, is a patient-specific, dendritic cell-based immunotherapy targeting glioblastoma and is currently being studied in an international Phase 3 trial. ImmunoCellular’s pipeline also includes: ICT-121, a patient-specific, dendritic cell-based immunotherapy targeting CD133 found in recurrent glioblastoma; ICT-140, a patient-specific, dendritic cell-based immunotherapy targeting ovarian cancer; and the Stem-to-T-cell research program which engineers hematopoietic stem cells to generate cytotoxic T cells. For more information, visit the company's website at imuc.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

ThursdayDec 07, 2017 12:30 pm

Arcimoto, Inc. (NASDAQ: FUV) Starts Presentation at LD Micro Main Event

Arcimoto (NASDAQ: FUV) develops and designs electric vehicles currently producing a three-wheeled motorcycle called the SRK. For more information, visit the company’s website at www.arcimoto.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and…

ThursdayDec 07, 2017 12:00 pm

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Starts Presentation at LD Micro Main Event

Onconova Therapeutics (NASDAQ:ONTX) is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes. Onconova's lead candidate, Rigosertib, is a proprietary Phase 3 small molecule agent, which the company believes blocks cellular signaling by targeting RAS effector pathways. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in the clinical stage and several pre-clinical programs. For…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: LD Micro Main Event

Biomerica, Inc. (NASDAQ: BMRA) Starts Presentation at LD Micro Main Event

Caladrius Biosciences, Inc. (NASDAQ: CLBS) Starts Presentation at LD Micro Main Event

US Nuclear Corp. (UCLE) Starts Presentation at LD Micro Main Event

Ampio Pharmaceuticals, Inc. (NYSE: AMPE) Starts Presentation at LD Micro Main Event

Digital Ally, Inc. (NASDAQ: DGLY) Starts Presentation at LD Micro Main Event

RadNet, Inc. (NASDAQ: RDNT) Starts Presentation at LD Micro Main Event

Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) Starts Presentation at LD Micro Main Event

ImmunoCellular Therapeutics Ltd. (NYSE: IMUC) Starts Presentation at LD Micro Main Event

Arcimoto, Inc. (NASDAQ: FUV) Starts Presentation at LD Micro Main Event

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Starts Presentation at LD Micro Main Event

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search